4. p.23 第46題 (E) p.36 第44題 (D) 出自：http://leukemia.emedtv.com/aml/aml-prognosis-p2.html The AML prognosis will depend on: The patient's age, general health, and number of white blood cells in the blood at diagnosis Whether the AML was caused by previous anticancer treatment The subtype of AML How well the leukemia responds to initial treatment Whether the AML is untreated or has recurred (come back) after being treated Whether there is a history of a blood disorder such as myelodysplastic syndrome Whether the AML has spread to the central nervous system (brain and spinal cord) or to other parts of the body. 輸入自動翻譯 AML 預後將取決於： ‧病人的年齡、 一般的健康狀況及在診斷血液中白細胞的數量 ‧是否 AML 造成了以前的抗腫瘤治療 ‧AML 的子類型 ‧在白血病以及回應初始治療 ‧AML 是否是未經處理或已再次出現 () 後回國接受治療 ‧是否有一種血液疾病如骨髓增生異常綜合征的歷史記錄 ‧是否 AML 已蔓延到中樞神經系統 （腦和脊髓） 或身體其他部位。 另外 Leukemia immunophenotype could define some particular types of Leukemia M0 AMLL with an important value in diagnosis, treatment and predicting prognosis. Immunophenotype is an important supplement to the diagnosis and typing of the acute Leukemia on the base of the morphology and cytochemistry. 大意是Immunophenotype對diagnosis重要 --

※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 114.38.0.47